Jason Aryeh

Mr. Jason M.
Aryeh is an Independent Director at Lifecore Biomedical, Inc., an Independent Non-Executive Director at Orchestra Biomed Holdings, Inc., an Independent Director at Anebulo Pharmaceuticals, Inc., an Independent Director at Ligand Pharmaceuticals, Inc., a Founder & Managing General Partner at JALAA Equities LP and a Member at Omicron Delta Epsilon.
He is on the Board of Directors at Lifecore Biomedical, Inc., Orchestra Biomed Holdings, Inc., Cytovia Therapeutics, Inc., Anebulo Pharmaceuticals, Inc., Orchestra BioMed, Inc., Ligand Pharmaceuticals, Inc. and Cytovia, Inc. (Massachusetts).
Mr. Aryeh was previously employed as a Vice Chairman by Immunomedics, Inc., an Independent Director by Aralez Pharmaceuticals, Inc., a Chairman by QLT, Inc., a Chairman by Novelion Therapeutics, Inc., an Independent Director by Myrexis, Inc., a Chairman by Rio Grande Renewables LLC, and an Independent Director by Nabi Biopharmaceuticals.
He also served on the board at Cystic Fibrosis Foundation Therapeutics, Inc. and CorMatrix Cardiovascular, Inc. He received his undergraduate degree from Colgate University.